Global Cancer/Tumor Profiling Market Report By Application (Clinical Applications, And Research Applications), Technology (Immunoassays, Hybridization, Next-Generation Sequencing, Mass Spectroscopy, And Other Technologies (Pyrosequencing And Sanger Sequencing)), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, And Other Cancer Types) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026

ID:VMR11210449
January 2020
Report Formats:

As per this study, the Global Cancer/Tumor Profiling Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.

Cancer/Tumor profiling is a technique intends to get knowledge about cancer profile and genomic alteration of a patient, which can offer useful insights related to the mechanism of cancer. Basically, this technique assists physicians to opt appropriate therapy, and at the same time eliminates the therapies, which are doubtful and avoid over-treatment of the patient. In addition, cancer profiling is not limited to common cancer such as breast cancer and lymphoma, but it is also useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia.
 
Market Dynamics
 
The growing number of cancer cases across the globe is the major factor driving the demand for cancer/tumor profiling. The increasing utility of biomarkers and funding for cancer research is further fuelling the market growth. In addition to this, efficient and effective result of this profiling is also boosting the market growth. However, high cost associated with the diagnosis and usage of these methods for the treatment may hamper the market growth.  Whereas, the rising need for point-of-care diagnostics and personalized medicines is expected to offer new opportunities growth to the market growth over the forecast period.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of cancer/tumor profiling.
 
Market Segmentation
 
The broad cancer/tumor profiling market has been sub-grouped into the application, technology and cancer type. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Application

  • Clinical Applications
  • Research Applications
 
By Technology
  • Immunoassays
  • Hybridization
  • Next-generation Sequencing
  • Mass Spectroscopy
  • Other Technologies (Pyrosequencing and Sanger Sequencing)
 
By Cancer Type
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Melanoma Cancer
  • Other Cancer Types
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for cancer/tumor profiling in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Cancer/Tumor Profiling Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the cancer/tumor profiling market include Claris Life Sciences, Personal Genome Diagnostics, Inc., Perthera, Inc., Foundation Medicine, Inc. V., Strand, ApoCell, Contextual Genomics, Agendia, and GenScript. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Cancer/Tumor Profiling  Market
       2.2. Global Cancer/Tumor Profiling  Market Snapshot
 
3 . CANCER/TUMOR PROFILING  – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Cancer/Tumor Profiling  Market
       3.3. Market Restraints of Cancer/Tumor Profiling  Market
       3.4. Opportunities of Cancer/Tumor Profiling  Market
       3.5. Trends of Cancer/Tumor Profiling  Market
       3.6. Porter’s Five Force Analysis of Cancer/Tumor Profiling  Market
       3.7. Cancer/Tumor Profiling  Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Application
           3.7.2 Market Attractive Analysis by Technology
           3.7.3 Market Attractive Analysis by Cancer Type
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Cancer/Tumor Profiling  Value Chain Analysis
       4.2. Cancer/Tumor Profiling  Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Cancer/Tumor Profiling  Raw Material Manufactures List
           4.2.3. Price Trend of Cancer/Tumor Profiling  Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL CANCER/TUMOR PROFILING  MARKET ANALYSIS BY APPLICATION
       5.1 Overview by Application
       5.2 Global Cancer/Tumor Profiling  Market Analysis by Application
       5.3 Market Analysis of Clinical Applications by Regions
       5.4 Market Analysis of Research Applications by Regions
 
6 . GLOBAL CANCER/TUMOR PROFILING  MARKET ANALYSIS BY TECHNOLOGY
       6.1 Overview by Technology
       6.2 Global Cancer/Tumor Profiling  Market Analysis by Technology
       6.3 Market Analysis of Immunoassays by Regions
       6.4 Market Analysis of Hybridization by Regions
       6.5 Market Analysis of Next-generation Sequencing by Regions
       6.6 Market Analysis of Mass Spectroscopy by Regions
       6.7 Market Analysis of Other Technologies (Pyrosequencing and Sanger Sequencing) by Regions
 
7 . GLOBAL CANCER/TUMOR PROFILING  MARKET ANALYSIS BY CANCER TYPE
       7.1 Overview by Cancer Type
       7.2 Global Cancer/Tumor Profiling  Market Analysis by Cancer Type
       7.3 Market Analysis of Breast Cancer by Regions
       7.4 Market Analysis of Lung Cancer by Regions
       7.5 Market Analysis of Colorectal Cancer by Regions
       7.6 Market Analysis of Prostate Cancer by Regions
       7.7 Market Analysis of Melanoma Cancer by Regions
       7.8 Market Analysis of Other Cancer Types by Regions
 
8 . GLOBAL CANCER/TUMOR PROFILING  MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Cancer/Tumor Profiling  Market Estimate by Country
           8.3.3. United State
           8.3.4. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Cancer/Tumor Profiling  Market Estimate by Market Segment
           8.4.3. Europe Cancer/Tumor Profiling  Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Cancer/Tumor Profiling  Market Estimate by Market Segment
           8.5.3. Asia Pacific Cancer/Tumor Profiling  Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.7. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Cancer/Tumor Profiling  Market Estimate by Market Segment
           8.6.3. Latin America Cancer/Tumor Profiling  Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview
           8.7.2. Middle East & Africa Cancer/Tumor Profiling  Market Estimate by Market Segment
           8.7.3. Middle East & Africa Cancer/Tumor Profiling  Market Estimate by Country
           8.7.4. Middle East
           8.7.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE CANCER/TUMOR PROFILING  COMPANIES
       9.1. Cancer/Tumor Profiling  Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF CANCER/TUMOR PROFILING  INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Agendia
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. ApoCell
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Claris Life Sciences
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Contextual Genomics
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Foundation Medicine, Inc. V.
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. GenScript
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Personal Genome Diagnostics, Inc.
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Perthera, Inc.
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Strand
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
 
11.  IMPACT ANALYSIS OF COVID-19 OUTBREAK
       11.1. Impact Analysis of Covid-19 Outbreak on the Market
           11.1.1. Direct Impact on Production
           11.1.2. Supply Chain and Market Disruption
           11.1.3. Financial Impact on Firms and Financial Markets
       11.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       11.3. Pre V/S Post COVID-19 Market
       11.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
       11.5. COVID-19: Micro and Macro Factor Analysis on the Market
    
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers 
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Clinical Applications by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Research Applications by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis by Technology (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Immunoassays by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Hybridization by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Next-generation Sequencing by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Mass Spectroscopy by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Other Technologies (Pyrosequencing and Sanger Sequencing) by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis by Cancer Type (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Breast Cancer by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Lung Cancer by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Colorectal Cancer by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Prostate Cancer by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Melanoma Cancer by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Other Cancer Types by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market by Geography (USD MN)
  • North America Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • North America Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • North America Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • North America Cancer/Tumor Profiling  Market Estimate by Country (USD MN)
  • United State Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • United State Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • United State Cancer/Tumor Profiling  Market Analysis by Cancer Type (USD MN)
  • Rest of North America Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • Rest of North America Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • Rest of North America Cancer/Tumor Profiling  Market Estimate by Cancer Type(USD MN)
  • Europe Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • Europe Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • Europe Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • United Kingdom Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • United Kingdom Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • United Kingdom Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • France Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • France Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • France Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • Germany Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • Germany Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • Germany Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • Rest of Europe Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • Rest of Europe Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • Rest of Europe Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • Asia Pacific Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • Asia Pacific Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • Asia Pacific Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • Asia Pacific Cancer/Tumor Profiling  Market Estimate by Country (USD MN)
  • China Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • China Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • China Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • Japan Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • Japan Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • Japan Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • India Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • India Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • India Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • Rest of Asia Pacific Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • Rest of Asia Pacific Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • Rest of Asia Pacific Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • Latin America Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • Latin America Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • Latin America Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • Latin America Cancer/Tumor Profiling  Market Estimate by Country (USD MN)
  • Brazil Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • Brazil Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • Brazil Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • Rest of Latin America Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • Rest of Latin America Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • Rest of Latin America Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • Middle East & Africa Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • Middle East & Africa Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • Middle East & Africa Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • Middle East & Africa Cancer/Tumor Profiling  Market Estimate by Country (USD MN)
  • Middle East Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • Middle East Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • Middle East Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • Africa Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • Africa Cancer/Tumor Profiling  Market Estimate by Technology (USD MN)
  • Africa Cancer/Tumor Profiling  Market Estimate by Cancer Type (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
  • Research Scope of Cancer/Tumor Profiling  Report
  • Market Research Process
  • Market Research Methodology
  • Global Cancer/Tumor Profiling  Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Cancer Type
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Cancer/Tumor Profiling  Market Analysis by Application (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Clinical Applications by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Research Applications by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis by Technology (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Immunoassays by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Hybridization by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Next-generation Sequencing by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Mass Spectroscopy by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Other Technologies (Pyrosequencing and Sanger Sequencing) by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis by Cancer Type (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Breast Cancer by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Lung Cancer by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Colorectal Cancer by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Prostate Cancer by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Melanoma Cancer by Geography (USD MN)
  • Global Cancer/Tumor Profiling  Market Analysis in Other Cancer Types by Geography (USD MN)
  • Latin America Cancer/Tumor Profiling  Market by Revenue
  • Middle East & Africa Cancer/Tumor Profiling  Market by Revenue
  • Recent Development in Cancer/Tumor Profiling  Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials